Document Type
Showing 1-30 of 79 results for "67-63-0"
The Effective Use of Protein Kinase Inhibitors
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105 83 69 90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21...
"Specialty Chemicals of Known Origin,Reduce Supply Chain Risk with Specialty Chemicals of Known Origin"
L Poly L-Lysine Hydrobromide L8295 25988-63-0 GMP 5 g Potassium Sulfate, EP RES0797P-A7 7778-80-5 GMP 1 kg, 10 kg, 25 kg Pyridoxine Hydrochloride 89794 58-56-0 GMP 50 g Sodium Butyrate, USP/NF ARK2161
The Effective Use of Protein Kinase Inhibitors
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105 83 69 90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21...
Product Information Sheet - I9516
Temperature Product Description Molecular Formula: C3H8O Molecular Weight: 60.10 CAS Number: 67-63-0 Boiling Point: 82.5 °C (760 torr)1 Density: 0.78505 g/ml (20 °C) Synonym: isopropanol, secondary
Data Sheet - A0795
tritiated RIA system is as follows: Cross-Reactant % Cross Reactivity 5�-Androstane-3,17-dione 67 for this product has been sent to the attention of the Dihydroepiandrostenedione 6 safety officer of
Data Sheet - T2080
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼67 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 63–85 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Data Sheet - T2080
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼67 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 63–85 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
Bromophenyl phenyl ether 61. Hexachlorobenzene 62. Pentachlorophenol 63. Phenanthrene-d10 (I.S.) 64. Phenanthrene 65. Anthracene 66. Carbazole 67. Di-n-butyl phthalate 68. Fluoranthene 69. Benzidine 70. Pyrene
LABORATORY NOTEBOOK ISSUANCE PAGE
22 22 .9 90 24 .3 05 39 .0 98 40 .0 78 85 .4 68 87 .6 2 13 2. 91 13 7. 33 (2 23 ) (2 26 ) 44 .9 56 47 .8 67 50 .9 ...
Protein Extraction for Proteomics
Trichloroacetic Acid, 100% (6.1 N) Deoxycholate, 0.2% solution Wash Solution, 25% acetone solution R: 11-35-66-67 S: 9-16-26-36/37/39-45 Protein Purification FLAG Affinity Purification ANTI-FLAG� M2-Agarose
Data Sheet - T2080
mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼67 kDa Precautions and Disclaimer This product is for R&D use only, not for drug, household, or other
Data Sheet - T2080
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼67 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 63–85 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Data Sheet - T2080
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼67 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 63–85 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
Data Sheet - T2080
0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol. Molecular mass: ∼67 kDa Purity: ≥70% (SDS-PAGE, see Figure 1) Specific Activity: 63–85 nmole/min/mg (see Figure 2) Precautions and Disclaimer This
LABORATORY NOTEBOOK ISSUANCE PAGE
22 22 .9 90 24 .3 05 39 .0 98 40 .0 78 85 .4 68 87 .6 2 13 2. 91 13 7. 33 (2 23 ) (2 26 ) 44 .9 56 47 .8 67 50 .9 ...
LABORATORY NOTEBOOK ISSUANCE PAGE
22 22 .9 90 24 .3 05 39 .0 98 40 .0 78 85 .4 68 87 .6 2 13 2. 91 13 7. 33 (2 23 ) (2 26 ) 44 .9 56 47 .8 67 50 .9 ...
Data Sheet - T9698
oxidized thioredoxin (Trx). The isozymes from mammalian sources vary in molecular mass between 55-67 kDa, compared to 35 kDa enzymes found in prokaryotes, plants, or yeast.1,2 Mammalian thioredoxin
Data Sheet - A0435
D., et al., Proc. Natl. Acad. Sci. USA, 82, 4673 (1985) 2. Fair, D.S. and R.A. Marlar, Blood, 67, 64 (1986) 3. Kisiel, W., J. Clin. Invest., 64, 761 (1979) 4. Weiss, P., et al., Thromb....
Product Information Sheet - CS1150
Cathepsin K inhibitor reduces breast cancer–induced osteolysis and skeletal tumor burden. Cancer Res., 67, 9894-9902 (2007). 7. Xiao, Y., et al., Cathepsin K in adipocyte differentiation and its potential
Reagents
precipitation, thus minimizing the total volume to be centrifuged for DNA or RNA recovery. Water: ≤0.05% [67-63-0] C3H8O FW 60.10 Reference 1. Sambrook, J., et al., Molecular Cloning: A Laboratory Manual
Product Information Sheet - N0788
nM ) 2.5 E 49 50 51 52 53 54 55 56 57 58 59 60 Negative siRNA control (30 nM) F 61 62 63 64 65 66 67 68 69 70 71 72 siRNA...
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
rt ic le O r d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 T e c h n i c a l S e r v i c e ...
FcFusionProteinSeparation
10 15 20 25 mAU 0 10 20 30 40 50 8. 67 8 10 .6 08 12 .4 63 13 .9 74 15 .4 40 19 .8 95 ...
Data Sheet - ISO1
Press, London (1983). 2. McDougal, J.S., et al., J. Immunol. Meth., 63, 281-290 (1983). 3. Beyer, C.F., J. Immunol. Meth., 67, 79-87 (1984). TROUBLESHOOTING Problem 1: No color obtained
Product Information Sheet - ISO1
Press, London (1983). 2. McDougal, J.S., et al., J. Immunol. Meth., 63, 281-290 (1983). 3. Beyer, C.F., J. Immunol. Meth., 67, 79-87 (1984). TROUBLESHOOTING Problem 1: ...
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 ( U S ) T e c h n i c a l S ...
Protein Tyrosine Phosphatases- Potential Roles in Disease
d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 ( U S ) T e c h n i c a l S ...
Aldrichimica Acta Volume 50 Number 3
30 examples 45–84% DG = Noteworthy Examples: O CN X DG Y Y = CO2Et, X = CO (67%) Y = CO2Et, X = O (65%) Y = SO2Ph, X = CO (65%) Y = SO2Ph, X =...
Celltransmissions Newsletter
is si o n s Vo l 2 0, N o. 1, 2 00 4 O rd er : 1- 80 0- 32 5- 30 10 Te ch ni ca l S ...
KERN ABT
........................... 67 15.5.2 Delimiter settings.................................................................................................................. 67 15.5.3 Parity settings....

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.